The White House announced a sharp drop in U.S. drug overdose deaths, citing new CDC data showing fatalities at their lowest level in roughly a decade. White House Office of National Drug Control Policy director Sara Carter attributed the decline to Trump administration policies, pointing to border security and efforts against trafficking organizations.

"The historic decline in drug overdose deaths demonstrates that America is unequivocally winning the fight against illicit drugs," Carter said, citing an "approximately 41.5% decrease in total drug overdose deaths compared to the peak under the previous administration."

But leading drug policy researchers challenge the White House timeline. CDC data shows overdose deaths began declining in spring 2023—while Joe Biden was still president—and have fallen for at least 39 consecutive months. The White House statement suggested most gains occurred in the past 18 months, a claim contradicted by the data.

Vanda Felbab-Brown, a drug policy expert at the Brookings Institution, confirmed the earlier start. "Since the spring of 2023, we have seen a steady decline in overdose deaths," Felbab-Brown said.

By the end of Biden's presidency, fatal overdoses had already decreased by roughly one-third—a shift addiction experts described as rare at the time.

Nabarun Dasgupta, a street drug researcher at the University of North Carolina at Chapel Hill and among the first scientists to identify the drop, said the trend began in some regions and demographic groups as early as 2021 before gaining nationwide momentum. The period from early 2024 through spring 2025 saw "the greatest rate of decline that we've ever seen," Dasgupta noted—a span covering both administrations.

Fentanyl deaths, driven by smuggling from Mexico, first began rising in 2013 during President Obama's tenure and accelerated during Trump's first term. They spiked sharply during Biden's first two years, coinciding with the COVID-19 pandemic. Fentanyl remains the leading cause of overdose deaths nationwide.